TY - JOUR
T1 - Rational development of bioprocess engineering strategies for recombinant protein production in Pichia pastoris (Komagataella phaffii) using the methanol-free GAP promoter. Where do we stand?
AU - García-Ortega, Xavier
AU - Cámara, Elena
AU - Ferrer, Pau
AU - Albiol, Joan
AU - Montesinos-Seguí, José Luis
AU - Valero, Francisco
N1 - Copyright © 2019 Elsevier B.V. All rights reserved.
PY - 2019/11/25
Y1 - 2019/11/25
N2 - © 2019 Elsevier B.V. The increasing demand for recombinant proteins for a wide range of applications, from biopharmaceutical protein complexes to industrial enzymes, is leading to important growth in this market. Among the different efficient host organism alternatives commonly used for protein production, the yeast Pichia pastoris (Komagataella phaffii) is currently considered to be one of the most effective and versatile expression platforms. The promising features of this cell factory are giving rise to interesting studies covering the different aspects that contribute to improving the bioprocess efficiency, from strain engineering to bioprocess engineering. The numerous drawbacks of using methanol in industrial processes are driving interest towards methanol-free alternatives, among which the GAP promoter-based systems stand out. The aim of this work is to present the most promising innovative developments in operational strategies based on rational approaches through bioprocess engineering tools. This rational design should be based on physiological characterization of the producing strains under bioprocess conditions and its interrelation with specific rates. This review focuses on understanding the key factors that can enhance recombinant protein production in Pichia pastoris; they are the basis for a further discussion on future industrial applications with the aim of developing scalable alternative strategies that maximize yields and productivity.
AB - © 2019 Elsevier B.V. The increasing demand for recombinant proteins for a wide range of applications, from biopharmaceutical protein complexes to industrial enzymes, is leading to important growth in this market. Among the different efficient host organism alternatives commonly used for protein production, the yeast Pichia pastoris (Komagataella phaffii) is currently considered to be one of the most effective and versatile expression platforms. The promising features of this cell factory are giving rise to interesting studies covering the different aspects that contribute to improving the bioprocess efficiency, from strain engineering to bioprocess engineering. The numerous drawbacks of using methanol in industrial processes are driving interest towards methanol-free alternatives, among which the GAP promoter-based systems stand out. The aim of this work is to present the most promising innovative developments in operational strategies based on rational approaches through bioprocess engineering tools. This rational design should be based on physiological characterization of the producing strains under bioprocess conditions and its interrelation with specific rates. This review focuses on understanding the key factors that can enhance recombinant protein production in Pichia pastoris; they are the basis for a further discussion on future industrial applications with the aim of developing scalable alternative strategies that maximize yields and productivity.
KW - Bioprocess efficiency
KW - Bioprocess engineering
KW - CONSTITUTIVE EXPRESSION
KW - FED-BATCH CULTIVATION
KW - GROWTH-RATE
KW - HGM-CSF EXPRESSION
KW - HUMAN SERUM-ALBUMIN
KW - Industrial recombinant protein production
KW - Komagataella phaffii
KW - MONOCLONAL-ANTIBODIES
KW - Methanol-free alternatives
KW - OPERATIONAL STRATEGIES
KW - Pichia pastoris
KW - RHIZOPUS-ORYZAE LIPASE
KW - SACCHAROMYCES-CEREVISIAE
KW - SCALE-UP
UR - http://www.mendeley.com/research/rational-development-bioprocess-engineering-strategies-recombinant-protein-production-pichia-pastori
U2 - 10.1016/j.nbt.2019.06.002
DO - 10.1016/j.nbt.2019.06.002
M3 - Review article
C2 - 31195158
SN - 1871-6784
VL - 53
SP - 24
EP - 34
JO - New Biotechnology
JF - New Biotechnology
ER -